FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndProvision for income taxes (Million JPY)YoY (%)
Mar 31, 2025-309-5446.90%
Mar 31, 20246-172.58%
Mar 31, 2023-8-102.59%
Mar 31, 2022308+2777.08%
Mar 31, 202111-131.13%
Mar 31, 2020-34-120.40%
Mar 31, 2019168-489.98%
Mar 31, 2018-43-89.94%
Mar 31, 2017-429-335.62%
Mar 31, 2016182+5.86%
Mar 31, 2015172
AI Chat